• Welcome to the online home of the Oman Medical Journal offering free access and publishing to all authors and researchers 

    Welcome from the Editor-in-Chief

    Prof. Ibrahim Al-Zakwani BSc, MSc, MS, PhD

    Welcome to the home of the Oman Medical Journal. The OMJ was established in 1984 and has been published under the Oman Medical Specialty Board since 2007. Initially, we started with one issue a year, which later increased to four and then to six in 2011. We currently publish over 100 articles a year covering all aspects of medicine and healthcare. These are selected by our committed and multi-disciplinary Editorial Board.

    We take a no barriers approach to publishing and are proud to offer the journal free to all those who wish to read it and charge no publication fees to authors/researchers. We publish a wide range of articles, including original research, case reports, and preliminary studies. We also publish editorials and letters intended to inform and spark debate about key medical issues. We do this to complement OMSB’s mission to provide quality healthcare through quality medical education. As part of this commitment, we are listed and indexed in over 35 databases, and this number continues to grow.

    We have added some exciting new features to this website. We now offer our authors the opportunity to publish their articles as soon as they are accepted with our preprint facility.  

    On behalf of the entire OMJ team, thank you for visiting the online home of the OMJ. We hope you will find this site to be a helpful resource. Please do not hesitate to contact us with any questions, concerns, or comments you have.

    Ibrahim Al-Zakwani

    Articles and Issues


    Most Viewed Articles

    The most viewed articles from the OMJ.
    Volume 36, Issue 1 January 2021
    The Post-acute COVID-19 Syndrome (Long COVID)

    Issa Al-Jahdhami, Khalid Al-Naamani, Adhra Al-Mawali

    Article history:

    Volume 36, Issue 1 January 2021
    Neutrophil-to-Lymphocyte Ratio as an Alternative Marker of Neonatal Sepsis in Developing Countries

    Khadijah Rizky Sumitro, Martono Tri Utomo, Agung Dwi Wahyu Widodo

    Objectives: We sought to analyze the neutrophil-to-lymphocyte ratio (NLR) as an alternative marker of neonatal sepsis. Methods: In this cross-sectional study, we undertook consecutive sampling in all inborn neonates admitted to the Neonatal Intensive Care Unit with clinical manifestations of neonatal sepsis. Neonates with congenital anomalies and referred neonates were excluded. Complete blood count, C-reactive protein (CRP), and blood culture were carried out as the septic workup examinations based on the local Clinical Practical Guidelines. NLR is obtained by dividing the absolute count of neutrophils from lymphocytes manually. A cut-off value of NLR is obtained using a receiver operating characteristic curve. Results: The median NLR value of the 104 neonates who met the inclusion and exclusion criteria was 3.63 (2.39–6.12). Neonates with NLR of 2.12 have the area under the curve of 0.630 (95% confidence interval (CI): 0.528–0.741) and 0.725 (95% CI: 0.636–0.814) when combined with CRP = 2.70 mg/dL. Neonates with NLR ≥ 2.12 in clinical neotnatal sepsis had almost double the risk of providing positive blood culture results (relative risk = 1.867, 95% CI: 1.077–3.235; p = 0.011). Conclusions: NLR, calculated from complete blood count, can be used as an alternative marker of easy and relatively inexpensive neonatal sepsis, especially in developing countries, and detection of proven neonatal sepsis to be better when combined with CRP.

    Article history:

    Volume 36, Issue 1 January 2021
    Prevalence of Gestational Diabetes Mellitus Using the Latest World Health Organization Diagnostic Criteria among Omani Women in Muscat, Oman

    Saada K. Al Subhi, Rahma M. Al Kindi, Abdul Hakim Al Rawahi, Iman S. Al Seyabi, Ameena Al Mukhaini

    Objectives: In 2013, the World Health Organization (WHO) recommended new criteria for diagnosing gestational diabetes mellitus (GDM). Our study aimed to compare the incidence of GDM and its complications among Omani pregnant women using the new diagnostic criteria compared to previous criteria published in 1999. Methods: This retrospective cohort study was conducted between January and December 2016 at the Bawshar Specialized Polyclinic in Muscat, Oman. A total of 613 Omani women were included in the study. Baseline maternal characteristics such as age, body mass index, parity, and socioeconomic status were recorded in addition to maternal and neonatal outcomes. Results: Based on the current diagnostic criteria, the incidence of GDM was 48.5% (n = 297); however, this dropped to 26.4% (n = 162) when applying the old criteria. Moreover, rates of maternal complications including polyhydramnios (5.6% vs. 4.6%), pregnancy-induced hypertension (3.2% vs. 1.5%), and preterm delivery (3.2% vs. 1.5%) were slightly higher among women with GDM diagnosed using the latest criteria. However, these differences were not statistically significant. Neonatal complications were also slightly more frequent among the first group, without any significant differences. Conclusions: The incidence of GDM among Omani women rose dramatically when utilizing the latest WHO diagnostic criteria, owing to a lower fasting blood glucose cut-off value. In addition, a comparison of the frequencies of maternal and neonatal complications supports the validity of the new criteria. These findings should be taken into consideration by decision-makers in Oman when planning antenatal and postnatal services.

    Article history:

    Online First
    Period-Prevalence and Publication Rate of Health Research Productivity in Seven Arabian Gulf Countries: Bibliometric Analysis from 1996 to 2018

    Yahya M. Al-Farsi, Nawaf H. Albali, Muneera K. Alsaqabi, Mohammed Sayed, Adhra H. Al-Mawali, Samir Al-Adawi

    Article history:

    Online First
    Significantly High Hba1c in Diabetic Patient with HbJ: Case Report

    Wan Nor Fazila Hafizan Wan Nik, Noorazliyana Shafii, Noor Azlin Azraini Che Soh Yusof, Rosnah Bahar

    Article history:

    Volume 36, Issue 2 March 2021
    Implications of the Emerging SARS-CoV-2 Variant: Caution is the Key

    Salah T. Al Awaidy, Rana Jawad Asghar, Saad Omais, Muhammad Salman, Hassan Zaraket

    Article history:

    Online First
    Cognitive Function in Adults with Thalassemia Major in Oman: A Pilot Study

    Shahina Daar, Muna Al Saadoon, Yasser Wali, Rawan Al Mujaini, Sarah Al Rahbi, Moon Fai Chan, Alya Al-Siyabi, Niveen Alansary, Sangeetha Mahadevan, Samir Al-Adawi

    Article history:

    Volume 36, Issue 1 January 2021
    Responses to the Pandemic COVID-19 in Primary Health Care in Oman: Muscat Experience

    Thamra Al Ghafri, Fatma Al Ajmi, Lamya Al Balushi, Padma Mohan Kurup, Aysha Al Ghamari, Zainab Al Balushi, Fatma Al Fahdi, Huda Al Lawati, Salwa Al Hashmi, Asim Al Manji, Abdallah Al Sharji

    Objectives: As coronavirus disease (COVID-19) was pervading different parts of the world, little has been published regarding responses undertaken within primary health care (PHC) facilities in Arabian Gulf countries. This paper describes such responses from January to mid-April 2020 in PHC, including public health measures in Muscat, Oman. Methods: This is a descriptive study showing the trends of the confirmed positive cases of COVID-19 and the undertaken responses to the evolving epidemiological scenario. These responses were described utilizing the World Health Organizations’ building blocks for health care systems: Leadership and governance, Health workforce, Service delivery, Medical products and technologies, and health information management. Results: In mid-April 2020, cases of COVID-19 increased to 685 (particularly among non-nationals). As the cases were surging, the PHC responded by executing all guidelines and policies from the national medical and public health response committees and integrating innovative approaches. These included adapting comprehensive and multi-sectoral strategies, partnering with private establishments, and strengthening technology use (in tracking, testing, managing the cases, and data management). Conclusions: Facilities in the Muscat governorate, with the support from national teams, seemed to continuously scale-up their preparedness and responses to meet the epidemiological expectations in the management of COVID-19.

    Article history:

    Volume 36, Issue 1 January 2021
    Self-management Education Program: The Case of Glycemic Control of Type 2 Diabetes

    Emmanuel Kumah, Aaron Asibi Abuosi, Samuel Egyakwa Ankomah, Cynthia Anaba

    Objectives: Self-management education (SME) is recognized globally as a tool that enables patients to achieve optimal glucose control. While factors influencing the effectiveness of self-management interventions have been studied extensively, the impact of program length on clinical endpoints of patients diagnosed with diabetes is underdeveloped. This paper synthesized information from the existing literature to understand the effect of program length on glycated hemoglobin (HbA1C) in adults with type 2 diabetes mellitus. Methods: We searched Web of Science, PubMed, Scopus, MEDLINE, EMBASE, PsychINFO, and the Cochrane Central Register of Controlled Trials to identify relevant English language publications on diabetes self-management education published between January 2000 and April 2019. Results: The review included 25 randomized controlled trials, with 64.0% reporting significant changes in HbA1C. The studies classified as long-term (lasting one year and above) were associated with the greatest number of interventions achieving statistically significant (87.5% significant vs. 12.5% non-significant) differences in changes in HbA1C between the intervention and the control subjects, recording an overall between-group HbA1C mean difference of 0.6±0.3% (range = 0.2–1.2). Conclusions: Our findings suggest that program length may change the effectiveness of educational interventions. Achieving sustained improvements in patients’ HbA1C levels will require long-term, ongoing SME, and support.

    Article history:

    For Authors

    The Oman Medical Journal accepts manuscript submissions through an external website, Editorial Manager.  

    The Journal has specific instructions and guidelines for submitting articles. Please read and review them carefully. Articles that are not submitted in accordance with our instructions and guidelines are more likely to be rejected.

    About OMJ

    Aims and scope
    Oman Medical Journal is an Open Access International Journal, which intends to engage and inform doctors, researchers and other health professionals by publishing a wide range of peer-reviewed articles. Our background is solidly grounded in publishing a high degree of articles covering all aspects of medicine.
    Information for subscribers
    Oman Medical Journal is published six times a year by Oman Medical Specialty Board. It is distributed free to all medical doctors and allied health professionals in various institutions locally and internationally.

    Charges: There is no charges for submission, publication, and subscription.
    Authorship criteria
    Each author must contribute a significant segment and should take responsibility for the content and authenticity of the work as a whole. Authors must complete an Authorship form clearly stating their responsibilities, contribution and financial sources. Authors must supply an email address as all correspondence will be by email.
    Abstracting and indexing services
    The journal is listed in PubMed and PubMed Central, and indexed in Index Medicus for the Eastern Mediterranean Region, Google Scholar, CrossRef, Index Copernicus, CINAHL, DOAJ, Global Health, Academic OneFile, Academic Science in Context, Academic Journals Database, CAB Abstracts, CABI Publishing, Chemical Abstracts, Cornell University Library, EBSCO Publishing Electronic Database, Embase, Electronic Journals Library (EZB), Expanded Academic ASAP, Genamics JournalSeek, Gale and Open J-Gate, GFMER, Health Reference Center, ICMJE, Newjour, SCIRUS, SCImago Journal & Country Rank, Scopus, Summon by Serial Solution, The John Rylands Library, UlrichsWeb Directory.

    Ethical considerations
    In all experiments and studies on humans or animals, authors must state whether formal approval from an Institutional Review Board or Ethics Committee was obtained in the Methods section of the manuscript. In the absence of such committee, the Declaration of Helsinki guidelines must be followed and be clearly stated. All studies on human subjects must include a statement that the subjects gave informed consent. Patient anonymity should be preserved. Photographs need to be cropped to prevent human subjects being recognized. Experiments involving animals must be demonstrated to be ethically acceptable and should conform to national guidelines for animal usage in research.
    Copyright and photocopying
    Open access agreement: Published manuscripts become the permanent property of Oman Medical Specialty Board. This open access journal is distributed under the terms of the Creative Commons Attribution-Non Commercial License (CC-BY-NC), permitting non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.
    Prof. Ibrahim Al-Zakwani, Sultan Qaboos University, Oman
    Associate Editors

    Dr. Abdulaziz Al-Mahrezi, Sultan Qaboos University Hospital, Oman

    Assoc.Prof. Murtadha Al-Khabori, Sultan Qaboos University, Oman

    Dr. Abdulhakeem Al-Rawahi, Oman Medical Speciality Board, Oman

    Statistics Editor
    Dr. Abdullah Al-Maniri, Oman Medical Speciality Board, Oman
    Editorial Board Members

    Prof. Samir Al-Adawi, Sultan Qaboos University, Oman

    Prof. Yasser Wali, Sultan Qaboos University, Oman

    Assoc.Prof. Abdullah Al-Mujaini, Sultan Qaboos University, Oman

    Dr. Adhra Al-Maawali, Ministry of Health, Oman

    Dr. Ahmed Al-Hashmi, Al-Nahdha Hospital, Oman

    Dr. Ahmed Al-Jahwari, Armed Forces Hospital, Oman

    Dr. Ahmed Al-Waily, Sultan Qaboos University Hospital, Oman

    Dr. Faryal Al-Lawati, Royal Hospital, Oman

    Dr. Hatem Al-Lawati, Sultan Qaboos University Hospital, Oman

    Dr. Khalid Al-Thuhli, Sultan Qaboos University, Oman

    Assoc.Prof. Khalid Al-Rasadi, Sultan Qaboos University, Oman

    Assoc.Prof. Khamis Al-Hashmi, Sultan Qaboos University, Oman

    Dr. Khulood Al-Maamari, Sultan Qaboos University Hospital, Oman

    Dr. Marwa Al-Riyami, Sultan Qaboos University Hospital, Oman

    Dr. Mujahid Al-Busaidi, Sultan Qaboos University Hospital, Oman

    Assoc. Prof. Nihal Al-Riyami, Sultan Qaboos University, Oman

    Dr. Rahma Al-Kindi, Sultan Qaboos University Hospital, Oman

    Assoc.Prof. Rashid Al-Abri, Sultan Qaboos University, Oman

    Assoc.Prof. Saif Al-Yaarubi, Sultan Qaboos University, Oman

    Dr. Saud Al-Shabibi, Royal Hospital, Oman

    Editorial Office
    Medical Editor
    Dr. Ayshe Ismail
    Editorial Assistants
    Ms. Bishara Al-Mahruqi - 2418 1069
    Mrs. Jenny Manoguid - 2418 1059
    Mrs. Charie Ricafort - 2418 1082
    Mrs. Rabha Al-Abdulsalaam - 2418 1151
    Mrs. Iman Al-Busaidi - 2418 1150
    Technical Editor/Web Designer
    Mr. Amir Hussain
    Board Members
    Prof. A G Pusalkar, Lilaviti Hospital, India
    Prof. Dimitri Mikhailidis, University College London, United Kingdom
    Prof. Gordon Ferns, University of Surrey, United Kingdom
    Prof. Kichu Nair, University of New Castle, Australia
    Prof. Thomas Walsh, Yale University, United States
    Prof. Walter Rosser, Queens University, Canada
    Prof. Dirk Deleu, Weil Cornell Medical College, Qatar
    Dr. Amy Young, Baylor College of Medicine, United States
    Dr. Bassem Saab, American University of Beirut Medical Center, Lebanon
    Dr. Celia Rodd, McGill University, Canada
    Dr. Helen Batty, University of Toronto, Canada
    Dr. Kenneth Mattox, Baylor College of Medicine, United States
    Dr. Khalid Al-Jabri, Al Mufraq Hospital, United Arab Emirates
    Dr. Mahfooz Farooqi, King Abdulaziz Medical City, Riyadh, Saudi Arabia
    Dr. Mary-Ann Fitzcharles, McGill University, Canada
    Dr. Michael Shevell, McGill University, Canada
    Dr. Murtada Shabrawi, Cairo University, Egypt
    Dr. Mustafa Afifi, Jumeira University, Dubai, UAE
    Dr. Thomas Harle, Emeritus at Wake Forest University Medical School, United State
    The OMJ expects that the articles it publishes will not have been published or released elsewhere before they are published in the OMJ. This allows time for the independent peer review of scientific findings before it is available to the public and protects the originality of content. Authors should also not release the details of their findings to the mass media before their work can is peer reviewed and published.
    All articles are immediately available for free online at omjournal.org.
    The OMJ uses a peer-review process to evaluate manuscripts for scientific accuracy, novelty, and importance. The careful editing process often requires extensive revisions and assures detailed checking for accuracy. Authors will be responsible for checking the accuracy of the final edit.

    All submitted manuscripts are read by the Editor-in-chief and at least one other board member. Only those papers that seem most likely to meet our editorial criteria are sent for formal review. Those papers judged by the Board Members to be of insufficient general interest or otherwise inappropriate are rejected without external review.

    Manuscripts judged to be of potential interest to our readership are sent for formal review, typically to two or three reviewers. The editors then make a decision based on the reviewers' advice, from several possibilities:

    • Accept for publication without alteration.
    • Accept after revision/extensive revision. Authors are invited to revise their manuscript to address specific concerns before a final decision is reached.
    • Reject, but indicate to the authors that further work might justify a resubmission.
    • Reject outright, typically on grounds of relevance, lack of novelty, or major technical and/or interpretational problems.
    Reviewers are welcome to recommend a particular course of action, but they will be considered along with other reviewers who may have different technical expertise and/or views. Typically, the Board Members make decisions based on conflicting advice and their understanding of the research. It can be the case that we do not always follow the recommendations of reviewers. We do not send details of the final decision to reviewers.

    In cases where the authors have been asked to revise their manuscript, we may return to reviewers for a second review. When reviewers agree to assess a paper, we consider this commitment to review subsequent revisions.

    We do not edit reviewers' reports; any comments that were intended for the authors are transmitted. Therefore, we asked that reviewers remain respectful in their comments avoiding statements that may cause needless offense.
    Manuscripts will be edited for brevity, clarity, grammar, spelling, and style. When the editing is extensive, with the possibility of altered meaning, queries are sent to the corresponding author by email. When a manuscript has been edited and prepared for publication, these will be sent to the author along with any final queries from the Copy Editor. Authors are expected to check the proof carefully, paying particular attention to the accuracy of equations, tables, illustrations, other numerical matter and references (which have been corrected for style but not checked for accuracy, which remains the responsibility of the author), and answer any queries. With page proofs, we request that the authors make the fewest possible alterations other than corrections of errors, and wherever a change is essential, only substituting as few words as possible occupying an approximately equal amount of space. If no corrections are received, the Editors reserve the right to correct the proof themselves. Equally, the Editors reserve the right to dismiss any changes that do not follow OMJ style or introduce errors in language. Corrections are generally not made to a manuscript once it has been published unless there is a significant error.
    The Editorial Board is a group of individuals committed to helping the OMJ produce an excellent multidisciplinary scientific publication of the highest quality. The publisher/editor-in-chief appoint editorial Board members. The editorial board is made up of an interdisciplinary mix from a wide range of disciplines. The main responsibilities of editorial board members are to provide strategic and operational advice (unsolicited, as well as in editorial board meetings) and to guide papers in their area of expertise through the peer-review process.

    Any manuscript submitted by an Editorial Board member will be treated in the same manner as any other manuscripts with both the Editorial Board member and reviewers blinded to one another in the review process.
    Material submitted to the OMJ journals must not be discussed with the media, except in the case of accepted contributions, which can be discussed with the media only once published. Authors that are contacted by the media about any OMJ should ask that the OMJ is credited in any news stories.
    The OMJ Editorial Board and publication staff keep all information about a submitted manuscript confidential and limited to those involved in the evaluation, review and publication process. The OMJ used a double-blind review process so that authors’ names and affiliations are not revealed to reviewers nor are reviewers’ names revealed to authors. Only information on accepted articles is archived for future reference.
    It is the responsibility of every person listed as an author of an article published in OMJ to have contributed in a meaningful and identifiable way to the design, performance, analysis, and reporting of the work, and agree to be accountable for all aspects of the work. Authors must complete an authorship form clearly stating their responsibilities, contribution, and financial sources.

    According to the guidelines of the International Committee of Medical Journal Editors (ICMJE), as revised in 2013, authorship credit should be based on the following 4 criteria: 

    • substantial contributions to conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; and
    • drafting of the work or revising it critically for important intellectual content; and
    • final approval of the version to be published; and
    • agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged.

    All authors (ie, the corresponding author and each coauthor) must read, complete, and submit an electronic Authorship Form with signed statements on Authorship Responsibility, Criteria, and Contributions and Confirmation of Reporting Conflicts of Interest and Funding.
    ©2021 All rights reserved to Oman Medical Journal. All articles published represent the opinions of the authors and do not reflect the official policy of the journal. This open access journal is distributed under the terms of Oman Medical Specialty Board, permitting non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. Published manuscripts become the permanent property of Oman Medical Specialty Board and may not be published elsewhere.
    A conflict of interest may exist when an author (or the author’s institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author’s decisions, work, or manuscript. All authors are required to complete and submit the ICMJE Form for Disclosure of Potential Conflicts of Interest: This form will be requested after a manuscript has been submitted, but authors should also include conflict of interest disclosures in the Disclosure section of the manuscript. Authors are expected to provide detailed information about all relevant financial interests, activities, relationships, and affiliations. Peer-reviewers are also expected to declare any conflicts of interest as part of their review.
    For all manuscripts reporting data from studies involving human participants, formal review and approval, or formal review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section. Such studies must also be in accordance with the Helsinki Declaration of 1975 (revised in 2008). For investigations of humans, state in the Methods section the manner in which informed consent was obtained from the study participants (ie, oral or written) and whether participants received a stipend. Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study.
    The OMJ uses the World Association of Medical Editors (WAME) definition of scientific misconduct as described below: 

    • Falsifying data: fabrication of data, selective reporting or omission, suppression or distortion of data. 
    • Plagiarism: using the published or unpublished language, ideas or thoughts of another writer without crediting the source and presenting them as one’s own. Plagiarism includes duplicate publication (publication of an article in more than one journal or in another language).
    • Authorship issues: exclusion of involved researchers or inclusion of researchers who have not contributed to the work or publication without permission from all authors. 
    • Violation of generally accepted research practice: including manipulating experiments/statistics to get biased results or improper reporting of results. 
    • Failure to follow legal requirements: violating local regulations and laws involving the use of funds, care of human subjects, investigational drugs, recombinant products, new devices or radioactive, biological or chemical materials.
    • Inappropriate behavior in cases of misconduct: including false accusations of misconduct; failure to report misconduct; not providing relevant information in a misconduct claim and retaliation against people claiming or investigating misconduct.

    All allegations of misconduct will be referred to the Editor-In-Chief. Authors will be contacted in writing with any concerns and asked to state their case and explain the circumstances. Until a decision about the manuscript is reached, work on the manuscript will be stopped. The Editor-in-Chief will make a final decision on the handling of the manuscript.
    General information
    All advertisements must comply the Oman Medical Journal advertising policy. Advertisers must be honest about their products and services. They should avoid misleading or offensive content to the reader. Any advertisement showing racial, ethnic, sexual, or religious bias will be rejected. Oman Med J have the right to decline any types of advertisement that is inappropriate and damaging to the content of the journal. Oman Med J may change the terms at any time, excluding advert approved prior to changes. Advertisers are hold liable for the content of their advertisements (including text, illustrations, trademarks, labels, or other copyright).

    All advertisements are subject for the approval of Oman Med J which may take up to five working days. Oman Med J have the right to reject and discontinue any advertisement for any reason. Advertisement is not related in any way to editorial decision, it is separate from the content of Oman Med J.

    What advert do we accept?
    • Pharmaceuticals and food supplements that are approved. 
    • Medical equipment
    • Conferences
    • CME programs and workshops

    Restricted products
    Advertisements relating to alcohol and tobacco will not be accepted as these are known to be harmful to health.

    Printing Details
    Oman Medical J is publishing every two months (bi-monthly). The schedule of publications are January, March, May, July, September, and November. If you want the advert to be included in an issue, the deadline of submission will be one month before the month of release. Example: advert for March issue should be submitted on or before February 1. Regarding the advert specification, we accept PDF, EPS, or TIFF format with 300 DPI or above. One full page is as big as A4 size (8.3” x 11.7”), and the price will vary according to the size and the page where the advert will appear. (Please see price below)

    Printing Details
    Position of Advert Cost per insertion
    Full page (inside page) 200 OMR
    Inside back cover 270 OMR
    Double page spread 350 OMR
    Half page (inside page) 160 OMR
    All advert are printed in full color. Oman Med J has the right to reject or discontinue any advertising for any reason including advertising that does not follow the publication’s standard. The advertiser is liable for the completeness and correctness of the advert. File that will be submitted to Oman Med J for advert is considered as a final and approved file.

    Cancellation Policy Cancellation should be made 15 days before the month of release. No cancellation is allowed less than 15 days before the month of release unless otherwise agreed by both parties in writing.

    Payment Terms Payment should be made in Omani Rial with net of 15 days from invoice date.

    Contacts For further queries, please feel free to email us at omj@omsb.org

    Contact Us

    "Our background is solidly grounded in publishing a high degree of articles covering all aspects of medicine."